UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
Tag: uva cancer center
Two new brain tumor medications could make a significant difference in the way tumors are treated — and in the lives of patients.
A tool created by UVA Health researchers is identifying new treatments for heart failure in drugs approved by the FDA for blood cancer.
Michael E. Williams, MD, is a hematology/oncology researcher at UVA Health, exploring ways to reduce chemotherapy use in blood cancer.
Targeting fusion proteins may provide an improved therapeutic approach for leukemia patients.
UVA Health is among the first 25 centers to bring cancer patients the MRIdian Linac, a significant advance in MR-guided radiation therapy.
Find out what cutting-edge genomics technology uncovered as the critical drivers of gut-related cancers.
UVA Health is testing whether smartwatch-based preconditioning can improve abdominal cancer surgical outcomes.
See how UVA Health's lung cancer surgeons earned a coveted 3 stars from The Society of Thoracic Surgeons.
No other center has the depth of scientific knowledge & translational research know-how to produce more unprecedented results for rare hematologic malignancies.